These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 5159117
1. Non-resting tremor in Parkinson's disease. Schwab RS, Young RR. Trans Am Neurol Assoc; 1971; 96():305-7. PubMed ID: 5159117 [No Abstract] [Full Text] [Related]
2. [The treatment of parkinsonism with amantadine]. Völler GW. Dtsch Med Wochenschr; 1970 Apr 24; 95(17):934-7. PubMed ID: 5439551 [No Abstract] [Full Text] [Related]
3. Amantadine hydrochloride in treatment of Parkinsonism. Nagaswami S, Nagaswami R. Dis Nerv Syst; 1973 Apr 24; 34(5):253-8. PubMed ID: 4782280 [No Abstract] [Full Text] [Related]
4. [Treatment of the Parkinson syndrome with amantadine]. Hartmann-von Monakow K. Schweiz Med Wochenschr; 1971 Dec 04; 101(48):1736-9. PubMed ID: 5140093 [No Abstract] [Full Text] [Related]
5. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine]. Sigwald J, Raymondeaud C, Piot C. Rev Neurol (Paris); 1970 Feb 04; 122(2):145-8. PubMed ID: 4931718 [No Abstract] [Full Text] [Related]
6. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa]. Fieschi C, Casacchia M, Nardini M, Reitano N. Minerva Med; 1971 Oct 31; 62(82):4040-2. PubMed ID: 5125075 [No Abstract] [Full Text] [Related]
7. [Amantadine hydrochloride in the treatment of Parkinson's syndrome]. De la Herrán J, Figuerido JA. Rev Esp Otoneurooftalmol Neurocir; 1971 Oct 31; 29(167):45-9. PubMed ID: 5091472 [No Abstract] [Full Text] [Related]
8. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease]. Hacohen H, Gurtner B. Schweiz Med Wochenschr; 1972 Apr 22; 102(16):583-6. PubMed ID: 5019377 [No Abstract] [Full Text] [Related]
9. Comparison of amantadine, placebo, and levodopa in Parkinson's disease. Bauer RB, McHenry JT. Neurology; 1974 Aug 22; 24(8):715-20. PubMed ID: 4858417 [No Abstract] [Full Text] [Related]
11. [Drug therapy of Parkinson's disease with amantadine and levodopa]. Fieschi C, Nardini M, Casacchia M, Reitano M, Tedone ME, Ferrari P, Robotti E. Sist Nerv; 1970 Aug 22; 22(2):126-43. PubMed ID: 5504552 [No Abstract] [Full Text] [Related]
13. [Amantadine in Parkinson's disease]. Vecchi L. Clin Ter; 1971 Jun 15; 57(5):471-5. PubMed ID: 5113576 [No Abstract] [Full Text] [Related]
14. [L-dopa effect in Parkinson's syndrome]. Römer F, Bettag W, Bock WJ. Z Allgemeinmed; 1971 Feb 28; 47(6):281-3. PubMed ID: 5571715 [No Abstract] [Full Text] [Related]
15. [Modern therapeutics of Parkinson's disease]. Schott B. Lyon Med; 1971 Nov 14; 226(17):539-46. PubMed ID: 5134684 [No Abstract] [Full Text] [Related]
16. [Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases]. Sigwald J, Raymondeaud C. Nouv Presse Med; 1972 Apr 29; 1(18):1237-9. PubMed ID: 5025538 [No Abstract] [Full Text] [Related]
17. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)]. Mazza C, Buffatti PF, Bazzan A, Lion P. Fracastoro; 1970 Apr 29; 63(5):768-73. PubMed ID: 5519378 [No Abstract] [Full Text] [Related]
18. Quantitative measurements of L-dopa therapy in Parkinson's disease. Webster DD. Trans Am Neurol Assoc; 1969 Apr 29; 94():348-50. PubMed ID: 5374483 [No Abstract] [Full Text] [Related]